Volume 102, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Puthiyakunnon S, Boddu S, Li Y, Zhou X, Wang C, Li J, Chen X, 2014. Strongyloidiasis–an insight into its global prevalence and management. PLoS Negl Trop Dis 8: e3018.
    [Google Scholar]
  2. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, Vounatsou P, Odermatt P, 2013. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7: e2288.
    [Google Scholar]
  3. Keiser PB, Nutman TB, 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208217.
    [Google Scholar]
  4. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J, 2008. Helminth infections: the great neglected tropical diseases. J Clin Invest 118: 13111321.
    [Google Scholar]
  5. Paltridge M, Smith S, Traves A, McDermott R, Fang X, Blake C, Milligan B, D’Addona A, Hanson J, 2020. Rapid progress towards elimination of strongyloidiasis in North Queensland, Tropical Australia. Am J Trop Med Hyg 102: 339345.
    [Google Scholar]
  6. Kearns TM et al., 2017. Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community. PLoS Negl Trop Dis 11: e0005607.
    [Google Scholar]
  7. Hays R, Esterman A, McDermott R, 2017. Control of chronic Strongyloides stercoralis infection in an endemic community may be possible by pharmacological means alone: results of a three-year cohort study. PLoS Negl Trop Dis 11: e0005825.
    [Google Scholar]
  8. Forrer A, Khieu V, Schindler C, Schär F, Marti H, Char MC, Muth S, Odermatt P, 2016. Ivermectin treatment and sanitation effectively reduce Strongyloides stercoralis infection risk in rural communities in Cambodia. PLoS Negl Trop Dis 10: e0004909.
    [Google Scholar]
  9. Miller A, Young EL, Tye V, Cody R, Muscat M, Saunders V, Smith ML, Judd JA, Speare R, 2018. A community-directed integrated Strongyloides control program in Queensland, Australia. Trop Med Infect Dis 3: E48.
    [Google Scholar]
  10. Buonfrate D, Young EL, Tye V, Cody R, Muscat M, Saunders V, Smith ML, Judd JA, Speare R, 2019. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. Lancet Infect Dis 19: 11811190.
    [Google Scholar]
  • Received : 10 Dec 2019
  • Accepted : 12 Dec 2019
  • Published online : 06 Jan 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error